US EditionA mixed-method study on antimicrobial resistance infection drivers in neonatal intensive care units: pathways, risks, and solutions - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
A mixed-method study on antimicrobial resistance infection drivers in neonatal intensive care units: pathways, risks, and solutions - AMR Insights
This study evaluates antimicrobial resistance (AMR) in neonatal intensive care units (NICUs) at Felege Hiwot Hospital. Out of 420 samples, 35% tested positive for AMR pathogens, with Coagulase-Negative Staphylococci, Klebsiella pneumoniae, and Acinetobacter spp. being the most prevalent. Resistance rates for Gentamicin, Cotrimoxazole, and Ciprofloxacin were alarmingly high, while Amikacin demonstrated low resistance. Risk factors such as imprope…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
